QDENGA can be administered to individuals irrespective of previous dengue exposure, without requiring pre-vaccination testing.

Takeda Biopharmaceuticals India has received market authorization for its dengue vaccine QDENGA. This vaccine is now approved for individuals aged four to sixty years old. QDENGA…

QDENGA can be administered to individuals irrespective of previous dengue exposure, without requiring pre-vaccination testing.

India approves Takeda's QDENGA dengue vaccine for ages 4-60, offering protection against all virus serotypes without prior screening.

Takeda's QDENGA is India's first dengue vaccine approved for use regardless of prior exposure, enhancing disease prevention efforts.

Japanese drug firm Takeda Biopharmaceuticals has received market authorisation from the Drug Controller General of India (DCGI) for QDENGA, making it the first dengue vaccine…

India's drug regulator has approved Takeda's Qdenga dengue vaccine, the first of its kind. This vaccine is expected to become available in India during the first half of 2027.…

País registrou mais de 1 milhão de casos desde 2021, com pelo menos 1.500 mortes

QDENGA, India's first dengue vaccine, receives approval for use, marking a significant milestone in dengue prevention efforts.

South Asian country grapples with sharp rise in cases over recent years

India a autorizat în premieră pe piaţa sa internă utilizarea unui vaccin împotriva febrei denga, Qdenga, fabricat de un producător japonez, a anunţat Ministerul indian al…

India has approved its first dengue vaccine. Doctors explain who can get it, how well it works, who should avoid it and why mosquito precautions still matter. | Health